MLSS MILESTONE SCIENTIFIC INC.
Price Chart
Executive Summary
Milestone Scientific implemented a stock option exchange program for its CEO and SVP, repricing underwater options from $0.46-$0.50 to $0.31 per share with accelerated vesting. Additionally, the Compensation Committee approved a new performance-based restricted stock unit (PRSU) sub-plan targeting up to 17.2M shares, subject to stockholder approval, with initial grants of 11.2M PRSUs to three officers tied to aggressive revenue, market cap, and acquisition milestones.
Actionable Insight
Monitor stockholder vote on share authorization for the PRSU plan. The aggressive performance targets (e.g., $50M market cap vs current $32M) suggest management confidence in growth, but the dilution is significant if achieved. Watch quarterly filings for progress toward milestones.
Key Facts
- Option exchange reprices 4 million shares from $0.45-$0.50 to $0.31 per share for CEO Eric Hines and SVP Jason Papes.
- Repriced options vest 25% immediately (500k shares) then 750k shares on each of the next two anniversaries.
- PRSU sub-plan authorizes up to 17,234,635 shares (Aggregate Pool), subject to stockholder approval.
- Initial PRSU grants total 11,202,513 shares: 5,170,391 to CEO Hines, 3,016,061 each to VP Harcum and SVP Papes.
- Performance period is Jan 1, 2026 to Dec 31, 2029; milestones include LTM net sales >$11M, >$13M, >$15M, market cap $50M, and a qualified acquisition >$10M revenue.
Financial Impact
Potential dilution from PRSUs: up to 17.2M new shares (53.8% of current shares if 32M outstanding?), plus 4M repriced options; no immediate cash impact.
Risk Factors
- Massive dilution if all PRSUs vest (up to 17.2M shares); current market cap only $32M.
- PRSU plan requires stockholder approval — failure could void grants.
- Aggressive revenue targets may be unmet, limiting incentive value but avoiding dilution.
Market Snapshot
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-021506 |
| Exhibit: ex10-3.htm | 0001493152-26-021506 |
| Exhibit: ex10-4.htm | 0001493152-26-021506 |
| Exhibit: ex10-1.htm | 0001493152-26-021506 |
| Document: form8-k.htm | 0001493152-26-021506 |
| Document: 0001493152-26-021506-index-headers.html | 0001493152-26-021506 |
| Document: 0001493152-26-021506-index.html | 0001493152-26-021506 |
| Document: 0001493152-26-021506.txt | 0001493152-26-021506 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
7d ago
|
S-3
| $0.3900 $0.4340 | ▼ −11.28% | ▼ −10.88% | $0.3860 (+1.03%) |
|
May 27, 2026
13d ago
|
Press Release
| $0.3900 $0.4000 | ▲ +2.56% | ▲ +2.01% | $0.3860 (−1.03%) |
|
May 14, 2026
26d ago
|
Press Release
| $0.3400 $0.3300 | ▼ −2.94% | ▼ −1.71% | $0.3860 (+13.53%) |
|
May 6, 2026
4w ago
|
8-K
| $0.4700 $0.4600 | ▼ −2.13% | ▼ −2.96% | $0.3860 (−17.87%) |
|
May 6, 2026
4w ago
|
8-K
| $0.4700 $0.4600 | ▼ −2.13% | ▼ −2.96% | $0.3860 (−17.87%) |
|
Apr 21, 2026
7w ago
|
8-K
| $0.3200 $0.3400 | ▲ +6.25% | ▲ +5.23% | $0.3860 (+20.63%) |
|
Apr 21, 2026
7w ago
|
Press Release
| $0.3200 $0.3400 | ▲ +6.25% | ▲ +5.23% | $0.3860 (+20.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access